These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 19932777

  • 1. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
    Hallén J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D.
    Am J Cardiol; 2009 Dec 01; 104(11):1472-7. PubMed ID: 19932777
    [Abstract] [Full Text] [Related]

  • 2. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E.
    J Cardiovasc Magn Reson; 2007 Dec 01; 9(5):749-58. PubMed ID: 17891611
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T.
    Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):307-14. PubMed ID: 18206741
    [Abstract] [Full Text] [Related]

  • 6. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months.
    Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S.
    Cardiology; 2009 Jan 22; 113(3):207-12. PubMed ID: 19218804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function.
    Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2192-4. PubMed ID: 17161244
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, Atsma DE, Schalij MJ, Jukema JW.
    Am J Cardiol; 2009 Mar 15; 103(6):779-84. PubMed ID: 19268731
    [Abstract] [Full Text] [Related]

  • 11. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cecchi E, Liotta AA, Gori AM, Valente S, Giglioli C, Lazzeri C, Sofi F, Gensini GF, Abbate R, Mannini L.
    Int J Cardiol; 2009 May 15; 134(2):189-94. PubMed ID: 18495262
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.
    Ohlmann P, Jaquemin L, Morel O, El Behlgiti R, Faure A, Michotey MO, Beranger N, Roul G, Schneider F, Bareiss P, Monassier JP.
    Am Heart J; 2006 Dec 15; 152(6):1161-7. PubMed ID: 17161070
    [Abstract] [Full Text] [Related]

  • 13. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Atar D, Huber K, Rupprecht HJ, Kopecky SL, Schwitter J, Theek C, Brandl K, Henning R, Geudelin B.
    Cardiology; 2007 Dec 15; 108(2):117-23. PubMed ID: 17019083
    [Abstract] [Full Text] [Related]

  • 14. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction.
    Sörensson P, Saleh N, Bouvier F, Böhm F, Settergren M, Caidahl K, Tornvall P, Arheden H, Rydén L, Pernow J.
    Heart; 2010 Nov 15; 96(21):1710-5. PubMed ID: 20956486
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction.
    Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, Laohachewin D, Zankl AR, Kaya Z, Bierhaus A, Giannitsis E, Katus HA, Korosoglou G.
    J Intern Med; 2011 Sep 15; 270(3):245-53. PubMed ID: 21362071
    [Abstract] [Full Text] [Related]

  • 17. Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.
    Husser O, Bodi V, Sanchis J, Nunez J, Mainar L, Rumiz E, Lopez-Lereu MP, Monmeneu JV, Forteza MJ, Oltra R, Riegger GA, Chorro FJ, Llacer A.
    Thromb Res; 2009 Nov 15; 124(5):592-600. PubMed ID: 19540571
    [Abstract] [Full Text] [Related]

  • 18. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
    Nilsson L, Hallén J, Atar D, Jonasson L, Swahn E.
    Heart; 2012 Jan 15; 98(1):31-6. PubMed ID: 21727201
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.